These data reveal a positive correlation between DHX9 expression, PC tumorigenesis and patient’s clinical outcome, hence suggesting the clinical relevance of DHX9 function in prostate carcinogenesis. The gene discussed is DHX9; the disease is urogenital neoplasm.